etorphine has been researched along with clocinnamox in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allen, RM; Dykstra, LA; Pitts, RC; Walker, EA | 1 |
| Kumar, P; Pawar, M; Sirohi, S; Sunkaraneni, S; Walker, EA; Yoburn, BC | 1 |
2 other study(ies) available for etorphine and clocinnamox
| Article | Year |
|---|---|
Clocinnamox antagonism of the antinociceptive effects of mu opioids in squirrel monkeys.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics, Non-Narcotic; Analgesics, Opioid; Anesthetics, Combined; Animals; Antigens, CD; Buprenorphine; Cell Adhesion Molecules; Cinnamates; Etorphine; Glycoproteins; Male; Morphine; Morphine Derivatives; Narcotic Antagonists; Pain Measurement; Saimiri | 1998 |
Opioid agonist efficacy predicts the magnitude of tolerance and the regulation of mu-opioid receptors and dynamin-2.
Topics: Alkylation; Analgesics, Opioid; Animals; Binding, Competitive; Cinnamates; Dose-Response Relationship, Drug; Down-Regulation; Drug Tolerance; Dynamin II; Etorphine; Male; Mice; Morphine; Morphine Derivatives; Narcotic Antagonists; Oxycodone; Pain Measurement; Pain Threshold; Predictive Value of Tests; Protein Processing, Post-Translational; Reaction Time; Receptors, Opioid, mu; Spinal Cord | 2007 |